nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—hematologic cancer	0.169	1	CbGaD
Levetiracetam—ABCC2—Daunorubicin—hematologic cancer	0.061	0.127	CbGbCtD
Levetiracetam—ABCB1—Lenalidomide—hematologic cancer	0.0339	0.0707	CbGbCtD
Levetiracetam—ABCC2—Irinotecan—hematologic cancer	0.0292	0.0608	CbGbCtD
Levetiracetam—ABCC2—Vinblastine—hematologic cancer	0.0259	0.054	CbGbCtD
Levetiracetam—ABCC2—Vincristine—hematologic cancer	0.0255	0.0531	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—hematologic cancer	0.0238	0.0496	CbGbCtD
Levetiracetam—ABCC2—Etoposide—hematologic cancer	0.0234	0.0487	CbGbCtD
Levetiracetam—ABCB1—Daunorubicin—hematologic cancer	0.0199	0.0414	CbGbCtD
Levetiracetam—ABCB1—Alitretinoin—hematologic cancer	0.0195	0.0406	CbGbCtD
Levetiracetam—ABCC2—Dexamethasone—hematologic cancer	0.0192	0.04	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—hematologic cancer	0.0159	0.0332	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—hematologic cancer	0.0154	0.0322	CbGbCtD
Levetiracetam—ABCB1—Imatinib—hematologic cancer	0.0152	0.0317	CbGbCtD
Levetiracetam—ABCB1—Nilotinib—hematologic cancer	0.0138	0.0288	CbGbCtD
Levetiracetam—ABCB1—Vinorelbine—hematologic cancer	0.0137	0.0286	CbGbCtD
Levetiracetam—ABCB1—Dasatinib—hematologic cancer	0.0122	0.0255	CbGbCtD
Levetiracetam—ABCB1—Mitoxantrone—hematologic cancer	0.0121	0.0252	CbGbCtD
Levetiracetam—ABCB1—Betamethasone—hematologic cancer	0.0108	0.0224	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—hematologic cancer	0.0107	0.0222	CbGbCtD
Levetiracetam—ABCB1—Prednisolone—hematologic cancer	0.0106	0.0221	CbGbCtD
Levetiracetam—ABCB1—Prednisone—hematologic cancer	0.01	0.0209	CbGbCtD
Levetiracetam—ABCB1—Irinotecan—hematologic cancer	0.00951	0.0198	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—hematologic cancer	0.00845	0.0176	CbGbCtD
Levetiracetam—ABCB1—Vincristine—hematologic cancer	0.00831	0.0173	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—hematologic cancer	0.00775	0.0162	CbGbCtD
Levetiracetam—ABCB1—Etoposide—hematologic cancer	0.00762	0.0159	CbGbCtD
Levetiracetam—ABCB1—Dexamethasone—hematologic cancer	0.00626	0.013	CbGbCtD
Levetiracetam—SV2A—blood—hematologic cancer	0.0053	0.167	CbGeAlD
Levetiracetam—ABCB1—Doxorubicin—hematologic cancer	0.00519	0.0108	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—hematologic cancer	0.00503	0.0105	CbGbCtD
Levetiracetam—SV2A—lung—hematologic cancer	0.00465	0.146	CbGeAlD
Levetiracetam—SV2A—testis—hematologic cancer	0.00438	0.138	CbGeAlD
Levetiracetam—CACNA1B—lung—hematologic cancer	0.00321	0.101	CbGeAlD
Levetiracetam—SV2A—lymph node—hematologic cancer	0.00318	0.1	CbGeAlD
Levetiracetam—CACNA1B—testis—hematologic cancer	0.00303	0.0953	CbGeAlD
Levetiracetam—CACNA1B—lymph node—hematologic cancer	0.0022	0.0691	CbGeAlD
Levetiracetam—ABCC2—blood—hematologic cancer	0.00119	0.0373	CbGeAlD
Levetiracetam—ABCC2—testis—hematologic cancer	0.000981	0.0309	CbGeAlD
Levetiracetam—ABCC2—lymph node—hematologic cancer	0.000711	0.0224	CbGeAlD
Levetiracetam—ABCB1—hematopoietic system—hematologic cancer	0.000644	0.0203	CbGeAlD
Levetiracetam—ABCB1—gonad—hematologic cancer	0.00049	0.0154	CbGeAlD
Levetiracetam—ABCB1—blood—hematologic cancer	0.000427	0.0134	CbGeAlD
Levetiracetam—ABCB1—bone marrow—hematologic cancer	0.000413	0.013	CbGeAlD
Levetiracetam—ABCB1—lung—hematologic cancer	0.000374	0.0118	CbGeAlD
Levetiracetam—ABCB1—testis—hematologic cancer	0.000353	0.0111	CbGeAlD
Levetiracetam—ABCB1—lymph node—hematologic cancer	0.000256	0.00805	CbGeAlD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	9.25e-05	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GRB2—hematologic cancer	9.24e-05	0.00169	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFA—hematologic cancer	9.21e-05	0.00168	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KITLG—hematologic cancer	9.08e-05	0.00166	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	9.05e-05	0.00165	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT5A—hematologic cancer	8.88e-05	0.00162	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN2B—hematologic cancer	8.8e-05	0.00161	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP7—hematologic cancer	8.69e-05	0.00159	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD86—hematologic cancer	8.51e-05	0.00155	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	8.46e-05	0.00155	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	8.42e-05	0.00154	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	8.41e-05	0.00154	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTP1—hematologic cancer	8.41e-05	0.00154	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HES1—hematologic cancer	8.39e-05	0.00153	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—S100A10—hematologic cancer	8.36e-05	0.00153	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NCOR1—hematologic cancer	8.35e-05	0.00152	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	8.33e-05	0.00152	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF1—hematologic cancer	8.25e-05	0.00151	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FOXO1—hematologic cancer	8.13e-05	0.00149	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFRB—hematologic cancer	8.12e-05	0.00148	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFRA—hematologic cancer	7.99e-05	0.00146	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JAK1—hematologic cancer	7.96e-05	0.00145	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PRKCG—hematologic cancer	7.96e-05	0.00145	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	7.77e-05	0.00142	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40—hematologic cancer	7.75e-05	0.00141	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—hematologic cancer	7.73e-05	0.00141	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HGF—hematologic cancer	7.73e-05	0.00141	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	7.5e-05	0.00137	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTHFR—hematologic cancer	7.38e-05	0.00135	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TERT—hematologic cancer	7.35e-05	0.00134	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HLA-A—hematologic cancer	7.35e-05	0.00134	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	7.31e-05	0.00133	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—HRAS—hematologic cancer	7.18e-05	0.00131	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFB—hematologic cancer	7.18e-05	0.00131	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—STAT1—hematologic cancer	7.02e-05	0.00128	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TSC2—hematologic cancer	7.02e-05	0.00128	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	6.93e-05	0.00127	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGFR3—hematologic cancer	6.75e-05	0.00123	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	6.72e-05	0.00123	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—PDGFB—hematologic cancer	6.65e-05	0.00121	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	6.46e-05	0.00118	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BAD—hematologic cancer	6.4e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.34e-05	0.00116	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.34e-05	0.00116	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.34e-05	0.00116	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOTCH1—hematologic cancer	6.34e-05	0.00116	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	6.22e-05	0.00114	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD80—hematologic cancer	6.21e-05	0.00113	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KIT—hematologic cancer	6.2e-05	0.00113	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTPN11—hematologic cancer	6.09e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD86—hematologic cancer	6.05e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	6.04e-05	0.0011	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL10—hematologic cancer	5.94e-05	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	5.94e-05	0.00108	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CREB1—hematologic cancer	5.9e-05	0.00108	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BRAF—hematologic cancer	5.82e-05	0.00106	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL4—hematologic cancer	5.78e-05	0.00105	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6R—hematologic cancer	5.75e-05	0.00105	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CREBBP—hematologic cancer	5.75e-05	0.00105	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.71e-05	0.00104	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	5.69e-05	0.00104	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	5.65e-05	0.00103	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	5.58e-05	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FASLG—hematologic cancer	5.52e-05	0.00101	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—HRAS—hematologic cancer	5.5e-05	0.001	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAP2K1—hematologic cancer	5.48e-05	0.001	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CD—hematologic cancer	5.45e-05	0.000995	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FAS—hematologic cancer	5.32e-05	0.000972	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	5.29e-05	0.000966	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	5.29e-05	0.000965	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	5.23e-05	0.000955	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF2—hematologic cancer	5.22e-05	0.000952	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.19e-05	0.000947	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3R1—hematologic cancer	5.14e-05	0.000939	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.01e-05	0.000915	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	5.01e-05	0.000914	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JAK2—hematologic cancer	5e-05	0.000913	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MDM2—hematologic cancer	4.88e-05	0.000891	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	4.85e-05	0.000886	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	4.85e-05	0.000885	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	4.82e-05	0.000881	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CB—hematologic cancer	4.75e-05	0.000867	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTOR—hematologic cancer	4.75e-05	0.000867	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD4—hematologic cancer	4.74e-05	0.000865	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	4.72e-05	0.000862	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	4.71e-05	0.000861	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	4.65e-05	0.000848	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.58e-05	0.000837	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN1B—hematologic cancer	4.46e-05	0.000814	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD80—hematologic cancer	4.42e-05	0.000806	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.32e-05	0.00079	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	4.31e-05	0.000787	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	4.29e-05	0.000783	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.2e-05	0.000767	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.17e-05	0.000761	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN1A—hematologic cancer	4.11e-05	0.000751	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—hematologic cancer	4.11e-05	0.00075	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—hematologic cancer	4.1e-05	0.000749	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	4.09e-05	0.000748	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.08e-05	0.000746	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.93e-05	0.000718	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EP300—hematologic cancer	3.91e-05	0.000715	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SRC—hematologic cancer	3.8e-05	0.000695	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	3.73e-05	0.000681	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT3—hematologic cancer	3.67e-05	0.00067	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NRAS—hematologic cancer	3.66e-05	0.000668	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.65e-05	0.000667	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.64e-05	0.000665	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	3.55e-05	0.000649	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK3—hematologic cancer	3.51e-05	0.00064	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IFNG—hematologic cancer	3.49e-05	0.000638	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	3.48e-05	0.000636	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	3.47e-05	0.000633	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.44e-05	0.000628	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—hematologic cancer	3.41e-05	0.000623	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—hematologic cancer	3.4e-05	0.000621	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	3.35e-05	0.000612	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.26e-05	0.000595	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	3.24e-05	0.000592	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	3.23e-05	0.000591	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	3.21e-05	0.000587	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—hematologic cancer	3.15e-05	0.000575	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	3.15e-05	0.000575	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	3.12e-05	0.000569	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	3.12e-05	0.000569	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—hematologic cancer	3.11e-05	0.000569	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—hematologic cancer	3.11e-05	0.000567	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—hematologic cancer	3.1e-05	0.000566	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	3.09e-05	0.000564	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.05e-05	0.000558	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	3.04e-05	0.000556	CbGpPWpGaD
Levetiracetam—Vomiting—Gemcitabine—hematologic cancer	2.99e-05	0.000113	CcSEcCtD
Levetiracetam—Insomnia—Dexamethasone—hematologic cancer	2.99e-05	0.000113	CcSEcCtD
Levetiracetam—Insomnia—Betamethasone—hematologic cancer	2.99e-05	0.000113	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.98e-05	0.000544	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.98e-05	0.000544	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.98e-05	0.000544	CbGpPWpGaD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.98e-05	0.000112	CcSEcCtD
Levetiracetam—Paraesthesia—Betamethasone—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Paraesthesia—Dexamethasone—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—hematologic cancer	2.96e-05	0.000112	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—hematologic cancer	2.95e-05	0.000112	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—hematologic cancer	2.94e-05	0.000111	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—hematologic cancer	2.94e-05	0.000111	CcSEcCtD
Levetiracetam—Nausea—Vincristine—hematologic cancer	2.94e-05	0.000111	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—hematologic cancer	2.94e-05	0.000111	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—hematologic cancer	2.93e-05	0.000111	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisolone—hematologic cancer	2.91e-05	0.00011	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—hematologic cancer	2.91e-05	0.00011	CcSEcCtD
Levetiracetam—Dyspepsia—Betamethasone—hematologic cancer	2.91e-05	0.00011	CcSEcCtD
Levetiracetam—Dyspepsia—Dexamethasone—hematologic cancer	2.91e-05	0.00011	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.9e-05	0.000529	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CA—hematologic cancer	2.89e-05	0.000529	CbGpPWpGaD
Levetiracetam—Asthenia—Etoposide—hematologic cancer	2.88e-05	0.000109	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—hematologic cancer	2.88e-05	0.000109	CcSEcCtD
Levetiracetam—Body temperature increased—Triamcinolone—hematologic cancer	2.88e-05	0.000109	CcSEcCtD
Levetiracetam—Decreased appetite—Dexamethasone—hematologic cancer	2.87e-05	0.000108	CcSEcCtD
Levetiracetam—Decreased appetite—Betamethasone—hematologic cancer	2.87e-05	0.000108	CcSEcCtD
Levetiracetam—Nausea—Irinotecan—hematologic cancer	2.86e-05	0.000108	CcSEcCtD
Levetiracetam—Nausea—Mitoxantrone—hematologic cancer	2.86e-05	0.000108	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—hematologic cancer	2.86e-05	0.000108	CcSEcCtD
Levetiracetam—Infection—Prednisone—hematologic cancer	2.86e-05	0.000108	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.86e-05	0.000521	CbGpPWpGaD
Levetiracetam—Mediastinal disorder—Epirubicin—hematologic cancer	2.85e-05	0.000108	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.85e-05	0.000108	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.85e-05	0.000108	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—hematologic cancer	2.85e-05	0.000107	CcSEcCtD
Levetiracetam—Fatigue—Betamethasone—hematologic cancer	2.85e-05	0.000107	CcSEcCtD
Levetiracetam—Fatigue—Dexamethasone—hematologic cancer	2.85e-05	0.000107	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—hematologic cancer	2.84e-05	0.000107	CcSEcCtD
Levetiracetam—Pain—Dexamethasone—hematologic cancer	2.82e-05	0.000107	CcSEcCtD
Levetiracetam—Pain—Betamethasone—hematologic cancer	2.82e-05	0.000107	CcSEcCtD
Levetiracetam—Nervous system disorder—Prednisone—hematologic cancer	2.82e-05	0.000106	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.81e-05	0.000512	CbGpPWpGaD
Levetiracetam—Alopecia—Epirubicin—hematologic cancer	2.8e-05	0.000106	CcSEcCtD
Levetiracetam—Skin disorder—Prednisone—hematologic cancer	2.79e-05	0.000105	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—hematologic cancer	2.79e-05	0.000105	CcSEcCtD
Levetiracetam—Vomiting—Cisplatin—hematologic cancer	2.78e-05	0.000105	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—hematologic cancer	2.77e-05	0.000105	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—hematologic cancer	2.77e-05	0.000105	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—hematologic cancer	2.77e-05	0.000105	CcSEcCtD
Levetiracetam—Rash—Cisplatin—hematologic cancer	2.76e-05	0.000104	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—hematologic cancer	2.76e-05	0.000104	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—hematologic cancer	2.75e-05	0.000104	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—hematologic cancer	2.74e-05	0.000104	CcSEcCtD
Levetiracetam—Anorexia—Prednisone—hematologic cancer	2.74e-05	0.000103	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—hematologic cancer	2.74e-05	0.000103	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.72e-05	0.000497	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Dexamethasone—hematologic cancer	2.72e-05	0.000103	CcSEcCtD
Levetiracetam—Feeling abnormal—Betamethasone—hematologic cancer	2.72e-05	0.000103	CcSEcCtD
Levetiracetam—Tension—Epirubicin—hematologic cancer	2.7e-05	0.000102	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Betamethasone—hematologic cancer	2.7e-05	0.000102	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.7e-05	0.000102	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.68e-05	0.00049	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Triamcinolone—hematologic cancer	2.68e-05	0.000101	CcSEcCtD
Levetiracetam—SV2A—Disease—HRAS—hematologic cancer	2.68e-05	0.000489	CbGpPWpGaD
Levetiracetam—Nervousness—Epirubicin—hematologic cancer	2.68e-05	0.000101	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—hematologic cancer	2.66e-05	0.000101	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—PHYH—hematologic cancer	2.66e-05	0.000485	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GMPS—hematologic cancer	2.66e-05	0.000485	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FTCD—hematologic cancer	2.66e-05	0.000485	CbGpPWpGaD
Levetiracetam—Dizziness—Etoposide—hematologic cancer	2.65e-05	0.0001	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—hematologic cancer	2.64e-05	9.98e-05	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—hematologic cancer	2.64e-05	9.98e-05	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—hematologic cancer	2.64e-05	9.96e-05	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.64e-05	0.000481	CbGpPWpGaD
Levetiracetam—Leukopenia—Methotrexate—hematologic cancer	2.63e-05	9.95e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.63e-05	0.00048	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.62e-05	9.89e-05	CcSEcCtD
Levetiracetam—Dizziness—Prednisolone—hematologic cancer	2.62e-05	9.87e-05	CcSEcCtD
Levetiracetam—Asthenia—Triamcinolone—hematologic cancer	2.61e-05	9.85e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Betamethasone—hematologic cancer	2.61e-05	9.85e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Dexamethasone—hematologic cancer	2.61e-05	9.85e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Dexamethasone—hematologic cancer	2.61e-05	9.85e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Betamethasone—hematologic cancer	2.61e-05	9.85e-05	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—hematologic cancer	2.6e-05	9.82e-05	CcSEcCtD
Levetiracetam—Insomnia—Prednisone—hematologic cancer	2.6e-05	9.81e-05	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—hematologic cancer	2.6e-05	9.8e-05	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—hematologic cancer	2.59e-05	9.77e-05	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisone—hematologic cancer	2.58e-05	9.74e-05	CcSEcCtD
Levetiracetam—Pruritus—Triamcinolone—hematologic cancer	2.57e-05	9.72e-05	CcSEcCtD
Levetiracetam—Cough—Methotrexate—hematologic cancer	2.57e-05	9.7e-05	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—hematologic cancer	2.57e-05	9.68e-05	CcSEcCtD
Levetiracetam—SV2A—Disease—IL6—hematologic cancer	2.56e-05	0.000468	CbGpPWpGaD
Levetiracetam—Convulsion—Methotrexate—hematologic cancer	2.55e-05	9.63e-05	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—hematologic cancer	2.55e-05	9.63e-05	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—hematologic cancer	2.55e-05	9.62e-05	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.55e-05	0.000465	CbGpPWpGaD
Levetiracetam—Agitation—Epirubicin—hematologic cancer	2.53e-05	9.56e-05	CcSEcCtD
Levetiracetam—Dyspepsia—Prednisone—hematologic cancer	2.53e-05	9.55e-05	CcSEcCtD
Levetiracetam—Rash—Etoposide—hematologic cancer	2.53e-05	9.55e-05	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—hematologic cancer	2.53e-05	9.54e-05	CcSEcCtD
Levetiracetam—Headache—Etoposide—hematologic cancer	2.51e-05	9.48e-05	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—hematologic cancer	2.51e-05	9.46e-05	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—hematologic cancer	2.51e-05	9.46e-05	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—hematologic cancer	2.51e-05	9.46e-05	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—hematologic cancer	2.5e-05	9.44e-05	CcSEcCtD
Levetiracetam—Decreased appetite—Prednisone—hematologic cancer	2.5e-05	9.43e-05	CcSEcCtD
Levetiracetam—Rash—Prednisolone—hematologic cancer	2.49e-05	9.42e-05	CcSEcCtD
Levetiracetam—Dermatitis—Prednisolone—hematologic cancer	2.49e-05	9.41e-05	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.49e-05	9.4e-05	CcSEcCtD
Levetiracetam—Fatigue—Prednisone—hematologic cancer	2.48e-05	9.36e-05	CcSEcCtD
Levetiracetam—Headache—Prednisolone—hematologic cancer	2.48e-05	9.36e-05	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—hematologic cancer	2.48e-05	9.35e-05	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—hematologic cancer	2.47e-05	9.34e-05	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—hematologic cancer	2.47e-05	9.31e-05	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—hematologic cancer	2.47e-05	9.31e-05	CcSEcCtD
Levetiracetam—Constipation—Prednisone—hematologic cancer	2.46e-05	9.28e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.45e-05	0.000447	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SMPD3—hematologic cancer	2.43e-05	0.000444	CbGpPWpGaD
Levetiracetam—Confusional state—Methotrexate—hematologic cancer	2.42e-05	9.14e-05	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.42e-05	0.000442	CbGpPWpGaD
Levetiracetam—Dizziness—Triamcinolone—hematologic cancer	2.41e-05	9.08e-05	CcSEcCtD
Levetiracetam—Cough—Epirubicin—hematologic cancer	2.4e-05	9.07e-05	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—hematologic cancer	2.4e-05	9.07e-05	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—hematologic cancer	2.39e-05	9.01e-05	CcSEcCtD
Levetiracetam—Infection—Methotrexate—hematologic cancer	2.39e-05	9.01e-05	CcSEcCtD
Levetiracetam—Nausea—Etoposide—hematologic cancer	2.38e-05	8.99e-05	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisone—hematologic cancer	2.37e-05	8.94e-05	CcSEcCtD
Levetiracetam—Asthenia—Dexamethasone—hematologic cancer	2.37e-05	8.94e-05	CcSEcCtD
Levetiracetam—Asthenia—Betamethasone—hematologic cancer	2.37e-05	8.94e-05	CcSEcCtD
Levetiracetam—SV2A—Disease—AKT1—hematologic cancer	2.36e-05	0.000432	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Methotrexate—hematologic cancer	2.36e-05	8.89e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.36e-05	0.00043	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Methotrexate—hematologic cancer	2.35e-05	8.88e-05	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Prednisone—hematologic cancer	2.35e-05	8.87e-05	CcSEcCtD
Levetiracetam—Nausea—Prednisolone—hematologic cancer	2.35e-05	8.87e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.35e-05	0.000428	CbGpPWpGaD
Levetiracetam—Myalgia—Epirubicin—hematologic cancer	2.35e-05	8.85e-05	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—hematologic cancer	2.35e-05	8.85e-05	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—hematologic cancer	2.35e-05	8.85e-05	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—hematologic cancer	2.34e-05	8.84e-05	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—hematologic cancer	2.34e-05	8.82e-05	CcSEcCtD
Levetiracetam—Pruritus—Betamethasone—hematologic cancer	2.34e-05	8.82e-05	CcSEcCtD
Levetiracetam—Pruritus—Dexamethasone—hematologic cancer	2.34e-05	8.82e-05	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—hematologic cancer	2.33e-05	8.81e-05	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.33e-05	8.79e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.32e-05	0.000424	CbGpPWpGaD
Levetiracetam—Vomiting—Triamcinolone—hematologic cancer	2.31e-05	8.73e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.31e-05	0.000422	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.3e-05	0.00042	CbGpPWpGaD
Levetiracetam—Rash—Triamcinolone—hematologic cancer	2.29e-05	8.66e-05	CcSEcCtD
Levetiracetam—Dermatitis—Triamcinolone—hematologic cancer	2.29e-05	8.65e-05	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—hematologic cancer	2.29e-05	8.64e-05	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—hematologic cancer	2.29e-05	8.64e-05	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—hematologic cancer	2.28e-05	8.61e-05	CcSEcCtD
Levetiracetam—Headache—Triamcinolone—hematologic cancer	2.28e-05	8.6e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Prednisone—hematologic cancer	2.27e-05	8.58e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Prednisone—hematologic cancer	2.27e-05	8.58e-05	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—hematologic cancer	2.27e-05	8.56e-05	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—TNF—hematologic cancer	2.26e-05	0.000413	CbGpPWpGaD
Levetiracetam—Diarrhoea—Betamethasone—hematologic cancer	2.26e-05	8.53e-05	CcSEcCtD
Levetiracetam—Diarrhoea—Dexamethasone—hematologic cancer	2.26e-05	8.53e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.25e-05	0.00041	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.25e-05	0.00041	CbGpPWpGaD
Levetiracetam—Infection—Epirubicin—hematologic cancer	2.23e-05	8.43e-05	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—hematologic cancer	2.22e-05	8.4e-05	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—hematologic cancer	2.21e-05	8.34e-05	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—hematologic cancer	2.2e-05	8.32e-05	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—hematologic cancer	2.2e-05	8.31e-05	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.19e-05	8.26e-05	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—hematologic cancer	2.18e-05	8.24e-05	CcSEcCtD
Levetiracetam—Dizziness—Dexamethasone—hematologic cancer	2.18e-05	8.24e-05	CcSEcCtD
Levetiracetam—Dizziness—Betamethasone—hematologic cancer	2.18e-05	8.24e-05	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—hematologic cancer	2.17e-05	8.2e-05	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	8.19e-05	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—hematologic cancer	2.17e-05	8.19e-05	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—hematologic cancer	2.17e-05	8.19e-05	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—hematologic cancer	2.16e-05	8.16e-05	CcSEcCtD
Levetiracetam—Nausea—Triamcinolone—hematologic cancer	2.16e-05	8.16e-05	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—hematologic cancer	2.16e-05	8.14e-05	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.16e-05	8.14e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.15e-05	0.000393	CbGpPWpGaD
Levetiracetam—Anorexia—Epirubicin—hematologic cancer	2.14e-05	8.09e-05	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—hematologic cancer	2.14e-05	8.06e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—ASNS—hematologic cancer	2.12e-05	0.000388	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—B3GAT1—hematologic cancer	2.12e-05	0.000388	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—DCK—hematologic cancer	2.12e-05	0.000388	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Prednisone—hematologic cancer	2.12e-05	7.99e-05	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—hematologic cancer	2.11e-05	7.98e-05	CcSEcCtD
Levetiracetam—Vomiting—Dexamethasone—hematologic cancer	2.1e-05	7.92e-05	CcSEcCtD
Levetiracetam—Vomiting—Betamethasone—hematologic cancer	2.1e-05	7.92e-05	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—hematologic cancer	2.1e-05	7.92e-05	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—hematologic cancer	2.09e-05	7.88e-05	CcSEcCtD
Levetiracetam—Rash—Dexamethasone—hematologic cancer	2.08e-05	7.86e-05	CcSEcCtD
Levetiracetam—Rash—Betamethasone—hematologic cancer	2.08e-05	7.86e-05	CcSEcCtD
Levetiracetam—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	7.85e-05	CcSEcCtD
Levetiracetam—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	7.85e-05	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.07e-05	7.83e-05	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—hematologic cancer	2.07e-05	7.82e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.07e-05	0.000378	CbGpPWpGaD
Levetiracetam—Headache—Betamethasone—hematologic cancer	2.07e-05	7.81e-05	CcSEcCtD
Levetiracetam—Headache—Dexamethasone—hematologic cancer	2.07e-05	7.81e-05	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—hematologic cancer	2.07e-05	7.8e-05	CcSEcCtD
Levetiracetam—Asthenia—Prednisone—hematologic cancer	2.06e-05	7.79e-05	CcSEcCtD
Levetiracetam—Pain—Methotrexate—hematologic cancer	2.05e-05	7.76e-05	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.05e-05	7.73e-05	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—hematologic cancer	2.04e-05	7.7e-05	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—hematologic cancer	2.04e-05	7.69e-05	CcSEcCtD
Levetiracetam—Pruritus—Prednisone—hematologic cancer	2.03e-05	7.68e-05	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—hematologic cancer	2.03e-05	7.68e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.03e-05	0.000371	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.03e-05	0.00037	CbGpPWpGaD
Levetiracetam—Skin disorder—Doxorubicin—hematologic cancer	2.02e-05	7.63e-05	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—hematologic cancer	2.02e-05	7.62e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.02e-05	0.000368	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HDC—hematologic cancer	2.01e-05	0.000368	CbGpPWpGaD
Levetiracetam—Somnolence—Epirubicin—hematologic cancer	2e-05	7.54e-05	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—hematologic cancer	1.98e-05	7.49e-05	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—hematologic cancer	1.98e-05	7.47e-05	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—hematologic cancer	1.98e-05	7.47e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.97e-05	0.00036	CbGpPWpGaD
Levetiracetam—Diarrhoea—Prednisone—hematologic cancer	1.97e-05	7.42e-05	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—hematologic cancer	1.96e-05	7.42e-05	CcSEcCtD
Levetiracetam—Nausea—Dexamethasone—hematologic cancer	1.96e-05	7.4e-05	CcSEcCtD
Levetiracetam—Nausea—Betamethasone—hematologic cancer	1.96e-05	7.4e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.96e-05	0.000358	CbGpPWpGaD
Levetiracetam—Decreased appetite—Epirubicin—hematologic cancer	1.95e-05	7.38e-05	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.94e-05	0.000355	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.94e-05	7.33e-05	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—hematologic cancer	1.94e-05	7.32e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.93e-05	0.000352	CbGpPWpGaD
Levetiracetam—Pain—Epirubicin—hematologic cancer	1.92e-05	7.26e-05	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—hematologic cancer	1.92e-05	7.26e-05	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.92e-05	0.000351	CbGpPWpGaD
Levetiracetam—Dizziness—Prednisone—hematologic cancer	1.9e-05	7.18e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—hematologic cancer	1.9e-05	7.17e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—hematologic cancer	1.9e-05	7.17e-05	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.9e-05	7.15e-05	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—hematologic cancer	1.88e-05	7.1e-05	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—hematologic cancer	1.87e-05	7.05e-05	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—hematologic cancer	1.85e-05	6.99e-05	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—hematologic cancer	1.85e-05	6.98e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—CDA—hematologic cancer	1.84e-05	0.000336	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Epirubicin—hematologic cancer	1.84e-05	6.94e-05	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—hematologic cancer	1.83e-05	6.91e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.83e-05	0.000334	CbGpPWpGaD
Levetiracetam—Vomiting—Prednisone—hematologic cancer	1.83e-05	6.9e-05	CcSEcCtD
Levetiracetam—Rash—Prednisone—hematologic cancer	1.81e-05	6.84e-05	CcSEcCtD
Levetiracetam—Dermatitis—Prednisone—hematologic cancer	1.81e-05	6.84e-05	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—hematologic cancer	1.81e-05	6.83e-05	CcSEcCtD
Levetiracetam—Headache—Prednisone—hematologic cancer	1.8e-05	6.8e-05	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.8e-05	6.78e-05	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—hematologic cancer	1.79e-05	6.77e-05	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—hematologic cancer	1.78e-05	6.72e-05	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—hematologic cancer	1.78e-05	6.72e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—hematologic cancer	1.78e-05	6.71e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—hematologic cancer	1.78e-05	6.71e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—PC—hematologic cancer	1.77e-05	0.000324	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-05	6.68e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.74e-05	0.000318	CbGpPWpGaD
Levetiracetam—Asthenia—Methotrexate—hematologic cancer	1.72e-05	6.51e-05	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—hematologic cancer	1.71e-05	6.47e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.71e-05	0.000313	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GBA—hematologic cancer	1.71e-05	0.000313	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.71e-05	0.000313	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.71e-05	0.000313	CbGpPWpGaD
Levetiracetam—Nausea—Prednisone—hematologic cancer	1.71e-05	6.45e-05	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.7e-05	0.000311	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-05	6.42e-05	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—hematologic cancer	1.7e-05	6.42e-05	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—hematologic cancer	1.66e-05	6.25e-05	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—hematologic cancer	1.64e-05	6.21e-05	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—hematologic cancer	1.64e-05	6.21e-05	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—hematologic cancer	1.64e-05	6.21e-05	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—hematologic cancer	1.61e-05	6.09e-05	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.59e-05	0.000291	CbGpPWpGaD
Levetiracetam—Pruritus—Epirubicin—hematologic cancer	1.59e-05	6e-05	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—hematologic cancer	1.59e-05	6e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—MTAP—hematologic cancer	1.57e-05	0.000286	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.56e-05	0.000286	CbGpPWpGaD
Levetiracetam—Diarrhoea—Epirubicin—hematologic cancer	1.54e-05	5.81e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.53e-05	0.00028	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Doxorubicin—hematologic cancer	1.53e-05	5.79e-05	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—hematologic cancer	1.53e-05	5.77e-05	CcSEcCtD
Levetiracetam—Rash—Methotrexate—hematologic cancer	1.51e-05	5.72e-05	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—hematologic cancer	1.51e-05	5.71e-05	CcSEcCtD
Levetiracetam—Headache—Methotrexate—hematologic cancer	1.5e-05	5.68e-05	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—hematologic cancer	1.49e-05	5.63e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.49e-05	0.000273	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.49e-05	0.000272	CbGpPWpGaD
Levetiracetam—Dizziness—Epirubicin—hematologic cancer	1.49e-05	5.61e-05	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—hematologic cancer	1.47e-05	5.56e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.44e-05	0.000264	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.44e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.44e-05	0.000262	CbGpPWpGaD
Levetiracetam—Vomiting—Epirubicin—hematologic cancer	1.43e-05	5.4e-05	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—hematologic cancer	1.43e-05	5.39e-05	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—hematologic cancer	1.42e-05	5.37e-05	CcSEcCtD
Levetiracetam—Rash—Epirubicin—hematologic cancer	1.42e-05	5.35e-05	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—hematologic cancer	1.42e-05	5.35e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.41e-05	0.000257	CbGpPWpGaD
Levetiracetam—Headache—Epirubicin—hematologic cancer	1.41e-05	5.32e-05	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—FHL2—hematologic cancer	1.4e-05	0.000255	CbGpPWpGaD
Levetiracetam—Dizziness—Doxorubicin—hematologic cancer	1.38e-05	5.19e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.37e-05	0.000251	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGRN—hematologic cancer	1.37e-05	0.00025	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.34e-05	0.000244	CbGpPWpGaD
Levetiracetam—Nausea—Epirubicin—hematologic cancer	1.34e-05	5.04e-05	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—hematologic cancer	1.32e-05	4.99e-05	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—hematologic cancer	1.31e-05	4.95e-05	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	4.95e-05	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—hematologic cancer	1.3e-05	4.92e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.3e-05	0.000238	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMMR—hematologic cancer	1.3e-05	0.000237	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH2—hematologic cancer	1.3e-05	0.000237	CbGpPWpGaD
Levetiracetam—Nausea—Doxorubicin—hematologic cancer	1.24e-05	4.66e-05	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.23e-05	0.000225	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ARNTL—hematologic cancer	1.22e-05	0.000223	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.2e-05	0.000219	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.19e-05	0.000218	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CA9—hematologic cancer	1.19e-05	0.000217	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACP5—hematologic cancer	1.19e-05	0.000217	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOR2—hematologic cancer	1.17e-05	0.000214	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH1—hematologic cancer	1.12e-05	0.000204	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.12e-05	0.000204	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.11e-05	0.000202	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TXN—hematologic cancer	1.1e-05	0.000201	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCC3—hematologic cancer	1.1e-05	0.000201	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTO1—hematologic cancer	1.1e-05	0.000201	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SPHK1—hematologic cancer	1.08e-05	0.000197	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.04e-05	0.000189	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.02e-05	0.000186	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CRABP1—hematologic cancer	1.01e-05	0.000184	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.01e-05	0.000184	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALOX5—hematologic cancer	9.83e-06	0.00018	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.83e-06	0.00018	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NUP98—hematologic cancer	9.52e-06	0.000174	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADCY7—hematologic cancer	9.24e-06	0.000169	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA3—hematologic cancer	9.24e-06	0.000169	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NUP214—hematologic cancer	9.18e-06	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG2—hematologic cancer	8.99e-06	0.000164	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTR—hematologic cancer	8.99e-06	0.000164	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENO2—hematologic cancer	8.82e-06	0.000161	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—hematologic cancer	8.55e-06	0.000156	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SDC1—hematologic cancer	8.36e-06	0.000153	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.3e-06	0.000152	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.01e-06	0.000146	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.5e-06	0.000137	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CD44—hematologic cancer	7.11e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NQO1—hematologic cancer	7.11e-06	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYCS—hematologic cancer	6.73e-06	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSP90AA1—hematologic cancer	6.68e-06	0.000122	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—hematologic cancer	5.93e-06	0.000108	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—hematologic cancer	5.45e-06	9.95e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOR1—hematologic cancer	5.45e-06	9.95e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—hematologic cancer	4.82e-06	8.79e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.05e-06	7.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CREBBP—hematologic cancer	3.75e-06	6.85e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.56e-06	6.49e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—hematologic cancer	3.51e-06	6.41e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.36e-06	6.13e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.1e-06	5.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—hematologic cancer	2.68e-06	4.89e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—EP300—hematologic cancer	2.55e-06	4.67e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.89e-06	3.45e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—hematologic cancer	1.54e-06	2.82e-05	CbGpPWpGaD
